Humanigen Inc (HGENQ)

[10nisman]

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Humanigen (HGEN – Research Report) today and set a price target of $28.00. The company's shares closed last Thursday at $1.77, close to its 52-week low of $1.67. According to TipRanks.com, Pantginis covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Bioline RX Ltd Sponsored ADR, and Lineage Cell Therapeutics. Humanigen has an analyst consensus of Moderate Buy, with a price target consensus of $28.00.

Good ole, Jo Pa. I'll give him one thing, he's consistent... How many times does one person need to reiterate?